Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Univ. of North Texas to Collaborate on Forensics

NEW YORK (GenomeWeb News) – Illumina today said that it has entered into a collaboration with the University of North Texas Health Science Center focused on applying the firm's next-generation sequencing technologies to forensics.

The firm will work with researchers at UNTHSC's Institute of Applied Genetics and the Department of Forensic and Investigative Genetics to develop and validate assays for forensic identification. The partners intend to study a range of genetic markers for human identity testing, pharmacogenetics for molecular autopsy, microbial forensics, and other markers and methods that could generate investigative leads in criminal cases or for national security applications.

"Our work with Illumina enables us to design sample preparation, analytical protocols, hardware, and software that expand the capabilities of forensic DNA analysts," Bruce Budowle, executive director of UNT's Institute of Applied Genetics and vice chair of the Department of Forensic and Investigative Genetics, said in a statement. "Results of these projects will allow forensic scientists to accelerate implementation of the next wave of forensic DNA analysis tools."

Further terms of the alliance were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.